Key Takeaways
- Honeywell Aerospace ($HON.A) revised its full-year revenue guidance down by 10%, from $14.5 billion-$15.0 billion to $13.0 billion-$13.5 billion.
- The company's shares ($HON.A) plummeted 18% to $88.50 in post-earnings trading on Thursday.
- JPMorgan Chase downgraded $HON.A from Overweight to Neutral, slashing its price target from $120 to $95.
- The disappointing debut raises questions about the standalone entity's operational resilience and growth trajectory post-separation.
- Analysts cited persistent supply chain issues and labor shortages as key drivers for the revised outlook.
Aerospace Sector Faces Headwinds After Honeywell Aerospace's Stumble
Honeywell Aerospace ($HON.A) reported first-quarter earnings per share of $0.85, significantly missing analyst consensus estimates of $1.10, marking a challenging debut as an independent public entity following its recent spin-off from Honeywell International ($HON). The company simultaneously slashed its full-year revenue guidance by 10%, projecting $13.0 billion-$13.5 billion, down from an earlier forecast of $14.5 billion-$15.0 billion. This substantial revision immediately fueled investor concern over the aerospace sector's recovery pace and the new entity's operational efficiencies.
In response to the unexpectedly weak performance and outlook, $HON.A shares plunged 18% to close at $88.50 on Thursday, marking its largest single-day decline since its public listing five months prior. Trading volume surged to more than three times its 30-day average, with over 15 million shares exchanging hands, reflecting a broad-based investor reassessment of the company's valuation and future prospects. The downturn erased approximately $5 billion from the company's market capitalization, impacting broader sentiment across the aerospace and defense industry.
Market Impact
The dramatic sell-off in Honeywell Aerospace shares pushed the stock to its lowest level since its public listing in October last year, breaching key technical support at $95.00. The 18% drop represented the largest percentage decline for a major aerospace component supplier in a single trading session since Boeing's ($BA) 25% plunge in March 2020 at the onset of the pandemic. This sharp correction also dragged down related aerospace manufacturing and defense stocks, with the iShares U.S. Aerospace & Defense ETF ($ITA) declining 2.5% on Thursday.
The negative sentiment extended beyond direct competitors, impacting suppliers and partners within the aerospace ecosystem. Companies like Raytheon Technologies ($RTX) and General Electric ($GE), which also have significant aerospace divisions, saw their shares decline by 1.8% and 1.2% respectively, as investors re-evaluated the broader sector's earnings potential. The market's reaction suggests a recalibration of growth expectations for commercial aviation's recovery and a heightened sensitivity to supply chain disruptions and inflationary pressures impacting manufacturing costs across the industry. The decline in $HON.A also placed downward pressure on the broader industrial sector, with the S&P 500 Industrials index ($XLI) experiencing a 0.8% dip.
What Analysts Are Saying
Following the earnings release, several prominent investment banks swiftly adjusted their ratings and price targets for Honeywell Aerospace. JPMorgan Chase downgraded $HON.A from an "Overweight" rating to "Neutral," concurrently lowering its 12-month price target from $120 to $95. According to JPMorgan analyst Stephen Smith, "The magnitude of the guidance cut, particularly on the EPS front, suggests deeper operational challenges than previously anticipated, especially concerning labor availability and raw material costs, which are eroding margins faster than revenue growth."
Similarly, Morgan Stanley analysts reiterated their "Equal-Weight" rating but reduced their price target from $115 to $90, citing "persistent supply chain bottlenecks and a slower-than-expected rebound in business jet demand." They noted, "While commercial aerospace recovery remains a long-term tailwind, the near-term execution risks highlighted by Honeywell Aerospace's debut are substantial and warrant a more cautious stance." The consensus full-year EPS estimate for $HON.A has now fallen from $4.90 to $4.00, reflecting the broad analytical recalibration.
Conversely, a minority of analysts, such as those at Jefferies, maintained a "Buy" rating, albeit with a reduced price target from $130 to $110. They argued that "the sell-off presents a compelling long-term entry point given the company's strong technological portfolio and eventual normalization of supply chains, projecting a recovery towards $4.50 EPS by fiscal year 2025." This bullish view hinges on the belief that the current operational headwinds are temporary, and the company's fundamental market position remains strong in the long run.
What to Watch
Investors will be closely monitoring Honeywell Aerospace's second-quarter earnings call, anticipated in late July, for any signs of stabilization in its supply chain and progress on cost control initiatives. Key metrics to watch include any further revisions to the recently lowered full-year guidance and commentary on order backlogs across its commercial and defense segments. The company's ability to demonstrate a clear path to margin recovery and achieve its revised operating profit margin target of 12% for the year will be crucial for investor confidence.
Furthermore, the performance of key industry peers, particularly major aircraft manufacturers like Boeing ($BA) and Airbus ($AIR.PA), will offer insights into the broader health of the aerospace market. Any significant shifts in global air travel demand or defense spending budgets, especially from the U.S. Department of Defense, could materially impact Honeywell Aerospace's outlook. Technically, the stock's ability to reclaim and hold the $95.00 level will be a near-term indicator of potential stabilization, while a sustained break below $85.00 could signal further downside risk. The company's upcoming investor day in September could also provide a fresh strategic roadmap and long-term targets, potentially offering a catalyst for a re-evaluation by the market.


